Polymorphisms in COX-2, NSAID use and risk of basal cell carcinoma in a prospective study of Danes

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 617, Issue 1-2, 2007, Pages 138-146

  Vogel, Ulla ^a,b   Christensen, Jane ^c   Wallin, Håkan ^a   Friis, Søren ^c   Nexø, Bjørn A ^d   Tjønneland, Anne ^c  

^a NATIONAL RESEARCH CENTRE FOR THE WORKING ENVIRONMENT   (Denmark)

^b ROSKILDE UNIVERSITY   (Denmark)

^c INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^d AARHUS UNIVERSITY   (Denmark)

Author keywords

Genetic epidemiology; Inflammation; NSAID; Population based; SNP

Indexed keywords

ADENINE; ALANINE; CYTOSINE; GUANINE; NONSTEROID ANTIINFLAMMATORY AGENT; PROLINE; THYMINE;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; BASAL CELL CARCINOMA; CANCER RISK; CONTROLLED STUDY; COX 2 GENE; DENMARK; DISEASE ASSOCIATION; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC EPIDEMIOLOGY; HETEROZYGOTE; HUMAN; IL10 GENE; IL1BETA GENE; IL6 GENE; IL8 GENE; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NUCLEIC ACID BASE SUBSTITUTION; POPULATION BASED CASE CONTROL STUDY; PPAR GAMMA2 GENE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEPTOR GENE; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARCINOMA, BASAL CELL; CASE-CONTROL STUDIES; CYCLOOXYGENASE 2; DENMARK; FEMALE; GENOTYPE; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; RISK FACTORS; SKIN NEOPLASMS;

EID: 33847765830     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2007.01.005     Document Type: Article

References (45)

1. Han J., Colditz G.A., and Hunter D.J. Risk factors for skin cancers: a nested case-control study within the Nurses' Health Study. Int. J. Epidemiol. 35 (2006) 1514-1521
2. Lock-Andersen J., Drzewiecki K.T., and Wulf. H.C. Naevi as a risk factor for basal cell carcinoma in Caucasians: a Danish case-control study. Acta Derm. Venereol. 79 (1999) 314-319
3. Lock-Andersen J., Drzewiecki K.T., and Wulf H.C. Eye and hair colour, skin type and constitutive skin pigmentation as risk factors for basal cell carcinoma and cutaneous malignant melanoma. A Danish case-control study. Acta Derm. Venereol. 79 (1999) 74-80
4. Yarosh D.B., Boumakis S., Brown A.B., Canning M.T., Galvin J.W., Both D.M., Kraus E., O'Connor A., and Brown D.A. Measurement of UVB-induced DNA damage and its consequences in models of immunosuppression. Methods 28 (2002) 55-62
5. Skiba B., Neill B., and Piva T.J. Gene expression profiles of TNF-alpha, TACE, furin, IL-1beta and matrilysin in UVA- and UVB-irradiated HaCat cells. Photodermatol. Photoimmunol. Photomed. 21 (2005) 173-182
6. Muller-Decker K., Neufang G., Berger I., Neumann M., Marks F., and Furstenberger G. Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 12483-12488
7. Fischer S.M. Is cyclooxygenase-2 important in skin carcinogenesis?. J. Environ. Pathol. Toxicol. Oncol. 21 (2002) 183-191
8. Sorensen H.T., Friis S., Norgard B., Mellemkjaer L., Blot W.J., McLaughlin J.K., Ekbom A., and Baron J.A. Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study. Br. J. Cancer 88 (2003) 1687-1692
9. Friis S., Sorensen H.T., McLaughlin J.K., Johnsen S.P., Blot W.J., and Olsen J.H. A population-based cohort study of the risk of colorectal and other cancers among users of low-dose aspirin. Br. J. Cancer 88 (2003) 684-688
10. Grau M.V., Baron J.A., Langholz B., Karagas M., Greenberg E.R., Stukel T.A., and Mandel J.S. Effect of NSAIDs on the recurrence of nonmelanoma skin cancer. Int. J. Cancer 119 (2006) 682-686
11. Zhang X., Miao X., Tan W., Ning B., Liu Z., Hong Y., Song W., Guo Y., Zhang X., Shen Y., Qiang B., Kadlubar F.F., and Lin D. Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer. Gastroenterology 129 (2005) 565-576
12. Campa D., Zienolddiny S., Maggini V., Skaug V., Haugen A., and Canzian F. Association of a common polymorphism in the cyclooxygenase-2 gene with risk of non-small cell lung cancer. Carcinogenesis 25 (2004) 229-235
13. Sorensen M., Autrup H., Tjonneland A., Overvad K., and Raaschou-Nielsen O. A genetic polymorphism in prostaglandin synthase 2 (8473, T → C) and the risk of lung cancer. Cancer Lett. 226 (2005) 49-54
14. Kim Y., and Fischer S.M. Transcriptional regulation of cyclooxygenase-2 in mouse skin carcinoma cells. Regulatory role of CCAAT/enhancer-binding proteins in the differential expression of cyclooxygenase-2 in normal and neoplastic tissues. J. Biol. Chem. 273 (1998) 27686-27694
15. Terry C.F., Loukaci V., and Green F.R. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J. Biol. Chem. 275 (2000) 18138-18144
16. Fishman D., Faulds G., Jeffery R., Mohamed-Ali V., Yudkin J.S., Humphries S., and Woo P. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J. Clin. Invest. 102 (1998) 1369-1376
17. Landi S., Moreno V., Gioia-Patricola L., Guino E., Navarro M., de Oca J., Capella G., and Canzian F. Association of common polymorphisms in inflammatory genes interleukin (IL)6, IL8, tumor necrosis factor alpha, NFKB1, and peroxisome proliferator-activated receptor gamma with colorectal cancer. Cancer Res. 63 (2003) 3560-3566
18. Hull J., Thomson A., and Kwiatkowski D. Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families. Thorax 55 (2000) 1023-1027
19. Zhang Q., Southall M.D., Mezsick S.M., Johnson C., Murphy R.C., Konger R.L., and Travers J.B. Epidermal peroxisome proliferator-activated receptor gamma as a target for ultraviolet B radiation. J. Biol. Chem. 280 (2005) 73-79
20. Masugi J., Tamori Y., Mori H., Koike T., and Kasuga M. Inhibitory effect of a proline-to-alanine substitution at codon 12 of peroxisome proliferator-activated receptor-gamma 2 on thiazolidinedione-induced adipogenesis. Biochem. Biophys. Res. Commun. 268 (2000) 178-182
21. Hwang I.R., Kodama T., Kikuchi S., Sakai K., Peterson L.E., Graham D.Y., and Yamaoka Y. Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection. Gastroenterology 123 (2002) 1793-1803
22. Kilpinen S., Huhtala H., and Hurme M. The combination of the interleukin-1alpha (IL-1alpha-889) genotype and the interleukin-10 (IL-10 ATA) haplotype is associated with increased interleukin-10 (IL-10) plasma levels in healthy individuals. Eur. Cytokine Netw. 13 (2002) 66-71
23. Macarthur M., Sharp L., Hold G.L., Little J., and El Omar E.M. The role of cytokine gene polymorphisms in colorectal cancer and their interaction with aspirin use in the northeast of Scotland. Cancer Epidemiol. Biomar. Prev. 14 (2005) 1613-1618
24. Vogel U., Olsen A., Wallin H., Overvad K., Tjonneland A., and Nexo B.A. Effect of polymorphisms in XPD, RAI, ASE-1 and ERCC1 on the risk of basal cell carcinoma among Caucasians after age 50. Cancer Detect. Prev. 29 (2005) 209-214
25. Vogel U., Olsen A., Wallin H., Overvad K., Tjonneland A., and Nexo B.A. No association between GPX Pro198Leu and risk of basal cell carcinoma. Cancer Epidemiol. Biomar. Prev. 13 (2004) 1412-1413
26. Vogel U., Olsen A., Wallin H., Overvad K., Tjonneland A., and Nexo B.A. No association between OGG1 Ser326Cys and risk of basal cell carcinoma. Cancer Epidemiol. Biomar. Prev. 13 (2004) 1680-1681
27. Tjonneland A., Gronbaek M., Stripp C., and Overvad K. Wine intake and diet in a random sample of 48763 Danish men and women. Am. J. Clin. Nutr. 69 (1999) 49-54
28. A. Tjonneland, A. Olsen, K. Boll, C. Stripp, J. Christensen, G. Engholm, K. Overvad, Study design, exposure variables, and socioeconomic determinants of participation in Diet, Cancer and Health: a population-based prospective cohort study of 57,053 men and women in Denmark, Scand. J. Pub. Health, in press.
29. Clayton D., and Hills M. Statistical Models in Epidemiology (1993), Oxford University Press, New York p. 162
30. Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucl. Acids Res. 16 (1988) 1215
31. Barlow W.E., Ichikawa L., Rosner D., and Izumi S. Analysis of case-cohort designs. J. Clin. Epidemiol. 52 (1999) 1165-1172
32. Barlow W.E. Robust variance estimation for the case-cohort design. Biometrics 50 (1994) 1064-1072
33. Nissen S.B., Tjonneland A., Stripp C., Olsen A., Christensen J., Overvad K., Dragsted L.O., and Thomsen B. Intake of vitamins A, C, and E from diet and supplements and breast cancer in postmenopausal women. Cancer Causes Control 14 (2003) 695-704
34. Festa F., Kumar R., Sanyal S., Unden B., Nordfors L., Lindholm B., Snellman E., Schalling M., Forsti A., and Hemminki K. Basal cell carcinoma and variants in genes coding for immune response, DNA repair, folate and iron metabolism. Mutat. Res. 574 (2005) 105-111
35. Bair III W.B., Hart N., Einspahr J., Liu G., Dong Z., Alberts D., and Bowden G.T. Inhibitory effects of sodium salicylate and acetylsalicylic acid on UVB-induced mouse skin carcinogenesis. Cancer Epidemiol. Biomar. Prev. 11 (2002) 1645-1652
36. Reeve V.E., Matheson M.J., Bosnic M., and Boehm-Wilcox C. The protective effect of indomethacin on photocarcinogenesis in hairless mice. Cancer Lett. 95 (1995) 213-219
37. Ma W.Y., Huang C., and Dong Z. Inhibition of ultraviolet C irradiation-induced AP-1 activity by aspirin is through inhibition of JNKs but not erks or P38 MAP kinase. Int. J. Oncol. 12 (1998) 565-568
38. Butler G.J., Neale R., Green A.C., Pandeya N., and Whiteman D.C. Non-steroidal anti-inflammatory drugs and the risk of actinic keratoses and squamous cell cancers of the skin. J. Am. Acad. Dermatol. 53 (2005) 966-972
39. Muller-Decker K., Furstenberger G., Neumann M., and Schnolzer M. Differential protein expression in the epidermis of wild-type and COX-2 transgenic mice. Skin Pharmacol. Physiol. 19 (2006) 89-94
40. Brecher A.R. The role of cyclooxygenase-2 in the pathogenesis of skin cancer. J. Drugs Dermatol. 1 (2002) 44-47
41. Tripp C.S., Blomme E.A., Chinn K.S., Hardy M.M., LaCelle P., and Pentland A.P. Epidermal COX-2 induction following ultraviolet irradiation: suggested mechanism for the role of COX-2 inhibition in photoprotection. J. Invest. Dermatol. 121 (2003) 853-861
42. Akunda J.K., Lao H.C., Lee C.A., Sessoms A.R., Slade R.M., and Langenbach R. Genetic deficiency or pharmacological inhibition of cyclooxygenase-1 or -2 induces mouse keratinocyte differentiation in vitro and in vivo. FASEB J. 18 (2004) 185-187
43. Lee J.L., Kim A., Kopelovich L., Bickers D.R., and Athar M. Differential expression of E prostanoid receptors in murine and human non-melanoma skin cancer. J. Invest. Dermatol. 125 (2005) 818-825
44. Ramsay R.G., Ciznadija D., Vanevski M., and Mantamadiotis T. Transcriptional regulation of cyclo-oxygenase expression: three pillars of control. Int. J. Immunopathol. Pharmacol. 16 (2003) 59-67
45. Ramsay R.G., Friend A., Vizantios Y., Freeman R., Sicurella C., Hammett F., Armes J., and Venter D. Cyclooxygenase-2, a colorectal cancer non-steroidal anti-inflammatory drug target, is regulated by c-MYB. Cancer Res. 60 (2000) 1805-1809